�ٺ���Ƶ

As I was growing up, team sports were a large part of my life. I pursued a career as a surgical oncologist because the field allows me to collaborate with a team of specialists to provide advanced, personalized patient care. In addition, my work requires performing complex surgeries and strongly emphasizes biomedical research.

I have a clinical and research interest in advanced or metastatic cancer that has spread to or originated from the peritoneal lining, also known as the abdominal wall. I specialize in cytoreductive surgery, which is a major abdominal operation that involves removing all visible tumor, which is often followed by heated intraperitoneal chemotherapy, commonly known as HIPEC, to destroy microscopic cancer cells. I also manage gastrointestinal cancers of the colon, rectum, appendix, and small bowel.

In addition, I received specialized surgical training to manage skin cancers such as melanoma, basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma, as well as rare soft tissue sarcomas arising from the abdomen, extremities, or trunk. I use minimally invasive procedures whenever possible to reduce recovery time and work with other cancer and plastic surgeons to achieve the best oncologic and cosmetic outcomes.

I empower patients through education about their condition and care plan, including details about surgery, potential lifestyle modifications, and other required treatments. No two patients or two cancers are the same. I routinely work with medical oncologists, radiation oncologists, nurse navigators, nutritionists, physical therapists, and social workers to provide individualized care.

I have published numerous peer-reviewed articles and book chapters and have presented my research at national meetings. My research focuses on using regional or organ-directed therapies, such as HIPEC, to treat advanced cancers. As a research fellow at the National Cancer Institute, I have studied immune-based therapies and the cellular environment of cancers and plan to translate my knowledge of this treatment to patients with metastatic cancer.

My goal is to bring new therapies and clinical trials that offer hope to patients who may be out of standard treatment options.